Stock Market News
JP Morgan hails Barclays's settlement with DoJ, keeps at 'overweight'
Analysts at JP Morgan stuck by their recommendation to 'overweight' on shares of Barclays after the lender announced that it had reached a settlement with the US Department of Justice.
In their opinion, the £1.4bn ($2bn) deal - which was at the low end of market expectations - marked a watershed moment in the lender's recovery story, likely heralding a shift towards increased capital returns.
Hence, the shares' risk-reward profile was still positive, they said, with Barclays's Tier-1 equity capital buffers also seen climbing from 13% at present to 14.5% by the end of 2020.
The settlement with the DoJ would likely also result in a "material" improvement in the group's PRA stress test performance.
Nonetheless, JP Morgan was not expecting any announcement on share buybacks until after the 2018 stress test results, which were expected in the last quarter of the year.
To take note of, some press reports had pegged the amount of its final settlement with the DoJ as high as $5bn.
JP Morgan left its estimates for Barclays's total litigation costs over 2018 to 2020 at £2.5bn, but with the bulk of those, to the tune of £1.5bn, now expected to be incurred this year.
The broker left its forecasts for earnings and dividens per share untouched, with the target price still at 250p.
"In terms of read-across, we believe that the cash settlement of $2bn may be seen as a helpful read across for RBS, but the lack of customer relief leaves some uncertainty remaining for RBS."
In their opinion, the £1.4bn ($2bn) deal - which was at the low end of market expectations - marked a watershed moment in the lender's recovery story, likely heralding a shift towards increased capital returns.
Hence, the shares' risk-reward profile was still positive, they said, with Barclays's Tier-1 equity capital buffers also seen climbing from 13% at present to 14.5% by the end of 2020.
The settlement with the DoJ would likely also result in a "material" improvement in the group's PRA stress test performance.
Nonetheless, JP Morgan was not expecting any announcement on share buybacks until after the 2018 stress test results, which were expected in the last quarter of the year.
To take note of, some press reports had pegged the amount of its final settlement with the DoJ as high as $5bn.
JP Morgan left its estimates for Barclays's total litigation costs over 2018 to 2020 at £2.5bn, but with the bulk of those, to the tune of £1.5bn, now expected to be incurred this year.
The broker left its forecasts for earnings and dividens per share untouched, with the target price still at 250p.
"In terms of read-across, we believe that the cash settlement of $2bn may be seen as a helpful read across for RBS, but the lack of customer relief leaves some uncertainty remaining for RBS."
Related share prices |
---|
Barclays (BARC) share price |
Royal Bank of Scotland Group (RBS) share price |
Stock News headlines are gathered from financial news sources around the web. Views and opinions on each item are from their respective authors and website. They are not opinions of LiveCharts.co.uk
Get a free widget for your website with our latest headlines.
You can now add our live prices and new headlines to your website.The news widget features quotes for Oil prices, spot Gold price and Indices plus a choice of news channel for healines.
Top Shares pages
- Share price quotes
- Share charts
- Share watch list
- Company Results Calendar
- Top Large UK Shares
- UK Market Sectors
- Stock market news
- Company news
- Share tips
- A-Z company search
More share features
POPULAR Share Prices
- Royal Mail share price
- Lloyds share price
- HSBC share price
- Barclays share price
- Prudential share price
- Santander share price
- NEXT share price
- Diageo share price
- BP share price
- Vodafone share price
- British Airways
- Centrica share price
- Tesco share price
- Taylor Wimpey Share Price
- National Grid
- GKP Share Price
- Marks and Spencer
- Rolls Royce
- Rio Tinto
- THG Share Price
- Aviva Share Price
- Boil Share price
- Easyjet Share Price
- Genedrive Share Price
- SSE Share Price
- IAG Share Price
- Boohoo share price
- HE1 share price
- AVCT share price
- BOOM share price